TEVA Animal Health Inc. is recalling 400,413 units of various veterinary medications including Levothyroxine Sodium, Phenylbutazone, Praziquantel, and Clindamycin Hydrochloride due to physical characteristic defects in the tablets. These medications are used to treat conditions such as thyroid issues, pain, and infections in animals, and the physical defects could impact the accuracy of the dosage or the effectiveness of the treatment. The affected products were distributed nationwide across the United States primarily to own-label distributors, veterinary drug distributors, and veterinary clinics. Owners should immediately consult their veterinarian if their pet is taking any of these specific medications.
The tablets have physical characteristic defects which may lead to incorrect dosing or inconsistent medication delivery, potentially resulting in under-treatment or over-treatment of the animal's underlying medical condition.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response